References
Baeza-Centurion, P., Miñana, B., Valcárcel, J., & Lehner, B. (2020). Mutations primarily alter the inclusion of alternatively spliced exons.Elife, 9 . doi:10.7554/eLife.59959
Balavoine, A. S., Bataille, P., Vanhille, P., Azar, R., Noël, C., Asseman, P., . . . Vantyghem, M. C. (2011). Phenotype-genotype correlation and follow-up in adult patients with hypokalaemia of renal origin suggesting Gitelman syndrome. Eur J Endocrinol, 165 (4), 665-673. doi:10.1530/eje-11-0224
Bao, S., Moakley, D. F., & Zhang, C. (2019). The Splicing Code Goes Deep. Cell, 176 (3), 414-416. doi:10.1016/j.cell.2019.01.013
Baralle, M., & Baralle, F. E. (2018). The splicing code.Biosystems, 164 , 39-48. doi:10.1016/j.biosystems.2017.11.002
Cartegni, L., Chew, S. L., & Krainer, A. R. (2002). Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet, 3 (4), 285-298. doi:10.1038/nrg775
Colussi, G., Bettinelli, A., Tedeschi, S., De Ferrari, M. E., Syrén, M. L., Borsa, N., . . . Bianchetti, M. G. (2007). A thiazide test for the diagnosis of renal tubular hypokalemic disorders. Clin J Am Soc Nephrol, 2 (3), 454-460. doi:10.2215/cjn.02950906
Dufner-Almeida, L. G., do Carmo, R. T., Masotti, C., & Haddad, L. A. (2019). Understanding human DNA variants affecting pre-mRNA splicing in the NGS era. Adv Genet, 103 , 39-90. doi:10.1016/bs.adgen.2018.09.002
Fraile-Bethencourt, E., Valenzuela-Palomo, A., Díez-Gómez, B., Caloca, M. J., Gómez-Barrero, S., & Velasco, E. A. (2019). Minigene Splicing Assays Identify 12 Spliceogenic Variants of BRCA2 Exons 14 and 15.Front Genet, 10 , 503. doi:10.3389/fgene.2019.00503
Fujimura, J., Nozu, K., Yamamura, T., Minamikawa, S., Nakanishi, K., Horinouchi, T., . . . Iijima, K. (2019). Clinical and Genetic Characteristics in Patients With Gitelman Syndrome. Kidney Int Rep, 4 (1), 119-125. doi:10.1016/j.ekir.2018.09.015
Goren, A., Ram, O., Amit, M., Keren, H., Lev-Maor, G., Vig, I., . . . Ast, G. (2006). Comparative analysis identifies exonic splicing regulatory sequences–The complex definition of enhancers and silencers. Mol Cell, 22 (6), 769-781. doi:10.1016/j.molcel.2006.05.008
Han, Y., Zhao, X., Wang, S., Wang, C., Tian, D., Lang, Y., . . . Shao, L. (2019). Eleven novel SLC12A1 variants and an exonic mutation cause exon skipping in Bartter syndrome type I. Endocrine, 64 (3), 708-718. doi:10.1007/s12020-019-01856-6
Jiang, L., Peng, X., Ma, J., Yuan, T., Qin, Y., Wang, O., . . . Chen, L. (2015). NORMOMAGNESEMIC GITELMAN SYNDROME PATIENTS EXHIBIT A STRONGER REACTION TO THIAZIDE THAN HYPOMAGNESEMIC PATIENTS. Endocr Pract, 21 (9), 1017-1025. doi:10.4158/ep14432.Or
Johnson, J. M., Castle, J., Garrett-Engele, P., Kan, Z., Loerch, P. M., Armour, C. D., . . . Shoemaker, D. D. (2003). Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.Science, 302 (5653), 2141-2144. doi:10.1126/science.1090100
Ko, K., & Kim, J. W. (2021). The First Korean Case of SLC12A3 Aberrant Skipping of Two Exons Detected by RNA Splicing Analysis. Case Rep Nephrol Dial, 11 (2), 210-213. doi:10.1159/000517139
Lin, J. H., Wu, H., Zou, W. B., Masson, E., Fichou, Y., Le Gac, G., . . . Chen, J. M. (2021). Splicing Outcomes of 5’ Splice Site GT>GC Variants That Generate Wild-Type Transcripts Differ Significantly Between Full-Length and Minigene Splicing Assays.Front Genet, 12 , 701652. doi:10.3389/fgene.2021.701652
Miao, Z., Gao, Y., Bindels, R. J., Yu, W., Lang, Y., Chen, N., . . . Shao, L. (2009). Coexistence of normotensive primary aldosteronism in two patients with Gitelman’s syndrome and novel thiazide-sensitive Na-Cl cotransporter mutations. Eur J Endocrinol, 161 (2), 275-283. doi:10.1530/eje-09-0271
Parmar, M. S., Muppidi, V., & Bashir, K. (2021). Gitelman Syndrome. InStatPearls . Treasure Island (FL): StatPearls Publishing
Copyright © 2021, StatPearls Publishing LLC.
Riveira-Munoz, E., Chang, Q., Godefroid, N., Hoenderop, J. G., Bindels, R. J., Dahan, K., & Devuyst, O. (2007). Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol, 18 (4), 1271-1283. doi:10.1681/asn.2006101095
Simon, D. B., Nelson-Williams, C., Bia, M. J., Ellison, D., Karet, F. E., Molina, A. M., . . . Lifton, R. P. (1996). Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet, 12 (1), 24-30. doi:10.1038/ng0196-24
Soemedi, R., Cygan, K. J., Rhine, C. L., Wang, J., Bulacan, C., Yang, J., . . . Fairbrother, W. G. (2017). Pathogenic variants that alter protein code often disrupt splicing. Nat Genet, 49 (6), 848-855. doi:10.1038/ng.3837
Suarez-Artiles, L., Perdomo-Ramirez, A., Ramos-Trujillo, E., & Claverie-Martin, F. (2018). Splicing Analysis of Exonic OCRL Mutations Causing Lowe Syndrome or Dent-2 Disease. Genes (Basel), 9 (1). doi:10.3390/genes9010015
Takeuchi, Y., Mishima, E., Shima, H., Akiyama, Y., Suzuki, C., Suzuki, T., . . . Abe, T. (2015). Exonic mutations in the SLC12A3 gene cause exon skipping and premature termination in Gitelman syndrome. J Am Soc Nephrol, 26 (2), 271-279. doi:10.1681/asn.2013091013
Tournier, I., Vezain, M., Martins, A., Charbonnier, F., Baert-Desurmont, S., Olschwang, S., . . . Tosi, M. (2008). A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects. Hum Mutat, 29 (12), 1412-1424. doi:10.1002/humu.20796
Vargas-Poussou, R., Dahan, K., Kahila, D., Venisse, A., Riveira-Munoz, E., Debaix, H., . . . Jeunemaitre, X. (2011). Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol, 22 (4), 693-703. doi:10.1681/asn.2010090907
Veltrop, M., & Aartsma-Rus, A. (2014). Antisense-mediated exon skipping: taking advantage of a trick from Mother Nature to treat rare genetic diseases. Exp Cell Res, 325 (1), 50-55. doi:10.1016/j.yexcr.2014.01.026
Wang, S., Wang, Y., Wang, J., Liu, Z., Zhang, R., Shi, X., . . . Shao, L. (2020). Six Exonic Variants in the SLC5A2 Gene Cause Exon Skipping in a Minigene Assay. Front Genet, 11 , 585064. doi:10.3389/fgene.2020.585064
Wu, Y., Zhang, Y., & Zhang, J. (2005). Distribution of exonic splicing enhancer elements in human genes. Genomics, 86 (3), 329-336. doi:10.1016/j.ygeno.2005.05.011
Zhang, R., Chen, Z., Song, Q., Wang, S., Liu, Z., Zhao, X., . . . Shao, L. (2021). Identification of seven exonic variants in the SLC4A1, ATP6V1B1, and ATP6V0A4 genes that alter RNA splicing by minigene assay.Hum Mutat, 42 (9), 1153-1164. doi:10.1002/humu.24246
Table 1.